David Rosenbaum

10PUBLICATIONS
41CO-AUTHORS
Traditional Chinese medicine and treatmentsPacific Peoples theory of change models for healthToxicology (incl. clinical toxicology)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 10, 2026
Efficacy of Tenapanor in Patients With or Without Prior Use of IBS-C Prescription Medications: A Post-hoc Analysis of Phase 3 Clinical Trials.

|Sep 04, 2026
Patients' Real-World Experiences With Pharmacologic Therapies for Irritable Bowel Syndrome With Constipation: A Mixed-Methods Analysis and Classification of Social Media and E-Forum Posts.

|Jan 28, 2026
Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post hoc analysis.

Brian E Lacy, Andrea S Shin, David J Cangemi

|Aug 31, 2018
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability.

Andrew J King, Matthew Siegel, Ying He

|Apr 13, 2018
An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675.

Bertram Pitt, Vanessa Zann, Chris Roe

|Jan 25, 2018
Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers.

David P Rosenbaum, Andrew Yan, Jeffrey W Jacobs

Pageof 2

Frequent Collaborators

3 joint publications

Susan Edelstein

1 joint publications

Andrew J King

1 joint publications

Ying He

1 joint publications

Baoming Nie